Title |
Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors
|
---|---|
Published in |
BMC Chemistry, September 2011
|
DOI | 10.1186/2191-2858-1-7 |
Pubmed ID | |
Authors |
Noriyasu Kato, Mitsuru Oka, Takayo Murase, Masahiro Yoshida, Masao Sakairi, Mirensha Yakufu, Satoko Yamashita, Yoshika Yasuda, Aya Yoshikawa, Yuji Hayashi, Masahiro Shirai, Yukie Mizuno, Mitsuaki Takeuchi, Mitsuhiro Makino, Motohiro Takeda, Takuji Kakigami |
Abstract |
Focused structure-activity relationships of isoindoline class DPP-IV inhibitors have led to the discovery of 4b as a highly selective, potent inhibitor of DPP-IV. In vivo studies in Wistar/ST rats showed that 4b was converted into the strongly active metabolite 4l in high yield, resulting in good in vivo efficacy for antihyperglycemic activity. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 21 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 33% |
Researcher | 3 | 14% |
Student > Bachelor | 2 | 10% |
Other | 2 | 10% |
Student > Master | 2 | 10% |
Other | 4 | 19% |
Unknown | 1 | 5% |
Readers by discipline | Count | As % |
---|---|---|
Chemistry | 12 | 57% |
Agricultural and Biological Sciences | 3 | 14% |
Medicine and Dentistry | 2 | 10% |
Nursing and Health Professions | 1 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Other | 0 | 0% |
Unknown | 2 | 10% |